A Hidden Clue in Your Genes
Some people with diabetes heal slowly after surgery. Others bounce back quickly. New research points to a hidden reason: a gene called PADI4.
This gene can make immune cells overreact in people with diabetes. That overreaction can delay healing and raise infection risk.
Diabetes affects how the body repairs tissue. Even small cuts or surgical wounds can become stubborn problems. About one in four people with diabetes will face a foot ulcer in their lifetime. Infections can follow, and healing can take weeks or months.
Doctors already watch blood sugar and wound care closely. But even with good care, some patients still struggle. That’s why researchers are looking for early clues that can predict trouble before it starts.
Old Thinking Versus New Insight
For years, doctors have measured markers in the blood that signal inflammation. These markers can show that damage has already happened. But they often can’t tell you who is at risk before a wound stalls.
Here’s the twist: this study looks at a gene that shapes how immune cells behave before surgery. That means it could help teams plan extra protection for high-risk patients ahead of time.
How Immune Cells Make Traps
Think of neutrophils as the body’s first responders. When they sense danger, they can release sticky webs called NETs (neutrophil extracellular traps). These webs catch germs, like a spider’s web catching flies.
But in diabetes, these nets can be too thick and too many. They can trap the good tissue along with the bad. That slows healing and raises infection risk.
PADI4 is like a switch that turns on NET production. When this switch is stuck “on,” neutrophils make more nets, faster. The gene variant in this study makes the switch more sensitive.
Researchers studied 687 surgical patients. About 45% had diabetes. They measured PADI4 gene activity before surgery and tracked healing outcomes.
They looked at two versions of the gene: a major haplotype and a minor haplotype. They also checked how much PADI4 protein was made and how many NETs neutrophils released.
Patients with diabetes had about nine times higher PADI4 activity before surgery compared to those without diabetes. That jump was even larger in patients who later developed wound healing problems.
Neutrophils carrying the minor haplotype made more PADI4 protein and released NETs more quickly. In simple terms, their immune response was on high alert.
Clinically, diabetes patients with the minor haplotype had the highest rates of delayed wound healing and infections. This suggests the gene variant helps explain why some patients struggle more than others.
This does not mean the test is available in clinics today.
Where This Fits In Care
Experts say this could become a practical tool. A simple blood test before surgery might flag high-risk diabetes patients. Teams could then add preventive steps: closer wound checks, stronger infection prevention, or tailored support for healing.
It’s not about changing diabetes treatment. It’s about adding a layer of precision to wound care.
Limits To Keep In Mind
This study is early. It shows a strong link, but it does not prove cause and effect. The findings need confirmation in larger, more diverse groups.
The test is not yet standardized for clinical use. More work is needed to confirm accuracy and usefulness across different hospitals and populations.
What Happens Next
Researchers will likely run larger trials to see if PADI4 haplotyping improves real-world outcomes. If validated, it could become part of pre-surgical screening for diabetes patients. That would help teams act early, before wounds stall.
